Zent2U is happy to announce the successful EU registration of Norepinephrine 1mg/ml concentrate for solution for infusion. At the moment, the harmonized phase of the procedure is finalized, and the national phases of the registration are ongoing in order to obtain the Marketing Authorizations across the European countries. 🌍
💊 Norepinephrine is indicated in adults for use as an emergency measure in the restoration of blood pressure in cases of acute hypotension.
Zentiva’s innovated formulation resulted in a product with a decreased content of preservatives, which can be stored in room-temperature conditions.
🤝 We are pleased to offer our partners this well-established yet innovated product, completing their portfolio of essential, critical care medicines.
📧 Partner up now and connect with our team today!
thomas.koene@zentiva.com - Thomas Koene - Head of Zent2U
tomas.pilarcik@zentiva.com – Tomas Pilarcik – Head of B2B Europe
rahul.padhye@zentiva.com – Rahul Padhye – Head of B2B International
nina.fuentes@zentiva.com – Nina Fuentes de Tienda – Key Account Manager B2B Europe
yuliyana.manolova@zentiva.com - Yuliyana Manolova - Head of Distribution and Clinical Trials
#bloodpressure #hypotension #B2B #Zent2U #Zentiva
